SHR-1819

· Guangdong Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for SHR-1819, covering 2024-01-23 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]